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Enfermedades Respiratorias, CIBERES, Spain and 8) CIBER en Epidemiología y Salud Pública CIBERESP, SpainAbstractMolecular epidemiology has transformed our knowledge of how tuberculosis (TB) is transmitted. Whole genome sequencing (WGS) has
reached unprecedented levels of accuracy. However, it has increased technical requirements and costs, and analysis of data delays results.
Our objective was to ﬁnd a way to reconcile speed and ease of implementation with the high resolution of WGS. The targeted regional
allele-speciﬁc oligonucleotide PCR (TRAP) assay presented here is based on allele-speciﬁc PCR targeting strain-speciﬁc single nucleotide
polymorphisms, identiﬁed from WGS, and makes it possible to track actively transmitted Mycobacterium tuberculosis strains. A TRAP assay
was optimized to track the most actively transmitted strains in a population in Almería, Southeast Spain, with high rates of TB. TRAP was
transferred to the local laboratory where transmission was occurring. It performed well from cultured isolates and directly from sputa,
enabling new secondary cases of infection from the actively transmitted strains to be detected. TRAP constitutes a fast, simple and low-
cost tool that could modify surveillance of TB transmission. This pilot study could help to deﬁne a new model to survey TB transmission
based on a decentralized multinodal network of local laboratories applying fast and low-cost TRAPs, which are developed by central
reference centres, tailored to the speciﬁc demands of transmission at each local node.
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Interventions to control tuberculosis (TB) at the individual
level are based on early diagnosis and appropriate treatment.
However, control of TB also requires action at the population
level. Continuous surveillance of local ongoing transmission
would make it possible to identify the most successfullyClinical Microbiology and Infection © 2014 European Society of Ctransmitted (noncontrolled) strains of Mycobacterium tubercu-
losis (MTB) and to design interventions to prevent their trans-
mission. Observation of transmission events after intervention
could act as a marker for evaluating the efﬁciency of the control
program.
Analysis of genotypic patterns, or ﬁngerprinting, provides an
accurate picture of the transmission dynamics of MTB. The
identiﬁcation of clustered cases infected by isolates sharing
identical genotypic patterns shows that many transmission
events are not efﬁciently identiﬁed by standard interview-based
epidemiologic surveys [1,2].
Two conditions must be met for a genotyping-based strategy
to be useful for epidemiologic purposes. First, it must haveClin Microbiol Infect 2015; 21: 249.e1–249.e9
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many genuinely linked cases as possible and rule out unlinked
cases. Second, it should provide ﬁngerprinting data sufﬁciently
quickly for them to be useful in controlling transmission.
Whole genome sequencing (WGS) reaches unprecedented
levels of accuracy and discriminatory power. Its recent appli-
cation in the analysis of TB transmission has proven revolu-
tionary [3–7]. However, generating and analysing WGS data is
complex and requires expertise; in addition, platform costs are
high. Consequently, results are delayed, thus making this
approach suitable for retrospective investigations but not—at
least for the moment— for tracking ongoing transmission. On
the other hand, polymerase chain reaction (PCR)–based
ﬁngerprinting strategies such as mycobacterial interspersed
repetitive units–variable number of tandem repeats (MIRU-
VNTR) are simpler and more easily implemented, and despite
their lower discriminatory power, they do provide data quickly,
even enabling real-time analysis of respiratory specimens at
diagnosis [8]. It seems that the development of MTB ﬁnger-
printing schemes is forcing us to choose between two possi-
bilities: improved discriminatory power, and fast availability of
ﬁngerprinting data for integration in control programs.
Our objective was to explore a third alternative that would
make it possible to reconcile the high resolution offered by
WGS with the speed and ease of implementation of simple
PCR-based strategies.
Our proposal, targeted regional allele-speciﬁc oligonucleo-
tide PCR (TRAP), is aimed at prioritizing resources in the
surveillance of the problematic strains driving the main
noncontrolled TB transmission events. TRAP involves the
application of WGS to identify speciﬁc single-nucleotide poly-
morphisms (SNPs) for each strain, which are then used as se-
lective targets when tailoring PCRs. Each assay is applied to
determine whether new incident cases in a region are infected
by actively transmitted strains. TRAP has the advantages that it
is easily transferred from sites where WGS data are analysed
and its tests can be tailored to the clinical setting where the
strains are actively transmitting. If successful, this epidemiologic
point-of-care technique will facilitate control of highly trans-
missible strains in the region, ultimately leading to lower inci-
dence rates [9,10].
We evaluated our TRAP strategy in the province of Almería,
Southeast Spain, which has one of the highest rates of TB
transmission in Spain and a complex epidemiology of trans-
mission, the result of the high proportion of undocumented
immigrants and a high percentage of clustered cases [2,11].
Because universal genotyping based on MIRU-VNTR was dis-
continued in December 2012, this location is an ideal scenario
in which to evaluate new, easily implemented strategies to
address the control of TB transmission in situ.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectMaterials and MethodsStrain selection
The strains selected as actively transmitted in Almería were
involved in clusters (deﬁned by MIRU-VNTR) that had to be
extensive (higher than average number of cases; 7 cases),
prolonged (persistently caused secondary cases over a long
period; >5 years) and active (remained active until the
population-based molecular epidemiology study was dis-
continued in December 2012).
WGS data
WGS data (accession no. ERP002297) were available for a
selection of representatives of the strains selected as actively
transmitted in Almería, which were analysed elsewhere in the
context of microevolution [12]. Brieﬂy, standard library
preparation protocols were used following the recommen-
dations for Illumina TruSeq DNA sample preparation. A HiSeq
2000 device generating 51–101 bp paired-end reads was used.
We selected those SNPs that were common to the strains of
the cluster but different from the reference strain used for the
analysis. As an additional criterion, we screened an in-house
database of 219 strains considered to represent the
geographic and phylogenetic diversity of MTB complex [13].
SNPs present in any of the strains of this global collection
were ruled out as cluster-speciﬁc SNPs (Supplementary
methods).
TRAP assay
The ﬁnal conditions for the TRAP assay (duplex PCR format)
were 1.6 mM MgCl2, 0.05 μM primers targeting Rv0102, 0.1
μM primers targeting Rv2839 (Supplementary Table 1), 200 μM
dNTPs and 0.4 μL AmpliTaq Gold (Applied Biosystems, Foster
City, CA, USA) in Madrid and 0.2 μL Hot Start (Qiagen,
GmbH, Hilden, Germany) in Almería in a ﬁnal reaction volume
of 50 μL. The PCR was run as follows: 95°C for 10 minutes
followed by 25 PCR cycles (or 40 when analysing clinical
specimens) of 95°C for 1 minute, 65°C for 1 minute, and 72°C
for 1 minute and 72°C for 10 minutes. A Veriti 96-well thermal
cycler was used in Madrid and a Gene Amp PCR system 9700
in Almería.
DNA extraction
One milliliter of either cultured MTB (after 2 weeks of growth
in Mycobacteria Growth Indicator Tube; Becton Dickinson,
Franklin Lakes, NJ, USA) or decontaminated sputum was
extracted using a column-based puriﬁcation method (QIAamp
DNA minikit protocol; Qiagen, Courtaboeuf, France) and
eluted in 100 μL of buffer AE.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
FIG. 1. Aerial photograph of Almería showing the geographic distribution of tuberculosis cases during the study period. Figures in circles with a white
border indicate the number of cases diagnosed in that area. Figures in circles without a border correspond to the number of cases for the geographic
clusters identiﬁed (areas where the number of cases found is higher than expected according to population, population density and area). The size of
the circles without a border is proportional to the number of cases accumulated in that geographic area, which is indicated by the number within the
circle. The circle with the number 158 corresponds to the geographic cluster for Roquetas.
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The isolates were genotyped using the MIRU-24 multiplex PCR
[14,15] as described in Alonso et al. [8] but with 20 cycles of
ampliﬁcation.
MTB isolates
The isolates from clusters B and F, the isolates used to test
speciﬁcity of the TRAP assay, and the prospective isolates for
the years 2013 and 2014 from cases in Roquetas, Almería, were
provided by Complejo Hospitalario Torrecárdenas, Almería.ResultsIdentiﬁcation of active target clusters
We ﬁrst decided where to pilot our strategy in the province of
Almería (1258 TB cases in the 2005–2012 period, 817 culture
positive and 85% of them genotyped by MIRU-VNTR). Poniente
is one of the three regions in Almería with the highestClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infrequency of TB cases (50% of all cases in 2005–2012; 78%
immigrants). Among the urban settings in this region, Roquetas
de Mar was selected because of the high concentration of cases
in a small area (60 km2; Fig. 1) and the high percentage of
clustered cases (56%), which indicates recent active
transmission.
Using data from the population-based molecular epidemi-
ology study run in Almería for 2003–2012, we sought events in
Roquetas that corresponded to noncontrolled (extensive,
prolonged and active) transmission events (Table 1). Two of the
analysed clusters, B and F, fulﬁlled all these criteria (Table 2).
Application of the TRAP assay to survey highly
transmitted strains
Our objective was to design an assay that made it possible to
determine in a single-tube reaction whether an incident case in
the study region, Roquetas, was infected by the strain of cluster B,
the strain of cluster F or by another strain other than B or F.We
decided that a duplex alelle-speciﬁc-oligonucleotide PCR formatfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
TABLE 1. MIRU-VNTR-deﬁned clusters with more than 3
cases and including patients from Roquetas
Cluster name No. of members Period* No. in Roquetas
30 (B) 14 2003–2012 11
15 12 2003–2010 1
74 10 2004–2008 5
708 10 2007–2012 1
633 (F) 8 2007–2012 5
454 7 2005–2009 2
691 7 2007–2012 1
730 6 2007–2012 3
885 6 2008–2011 2
29 5 2006–2010 2
348 5 2005–2012 4
967 5 2008–2012 1
1202 4 2010–2011 2
347 4 2006–2010 2
490 4 2006–2011 3
558 4 2007–2011 1
775 4 2008–2010 1
849 4 2008–2011 2
MIRU-VNTR, mycobacterial interspersed repetitive units–variable number of
tandem repeats.
*Year in which the clustered subjects had active tuberculosis.
FIG. 2. (a) Schematic representation for the single-tube TRAP assay
illustrating the behavior of the two allele-speciﬁc PCRs targeting the
genes where the two selected SNPs speciﬁc for strains B and F mapped.
The selective primers PS1 and PS2 were designed to be homologous
with the alleles found in strains other than B or F. (b) Gel showing the
patterns expected for the TRAP assay; the 100 bp ladder is included. (c)
Gel representative of a second-line conﬁrmatory PCR. The conﬁrma-
tory PCR uses selective primers annealing with the alleles speciﬁc for B
and F strains. TRAP, targeted regional allele-speciﬁc oligonucleotide
PCR; PCR, polymerase chain reaction.
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regional allele-speciﬁc oligonucleotide PCR (TRAP).”
After an optimization stage using a selection of strain-speciﬁc
SNPs (Supplementary Methods), the best performance of
TRAP, according to intensity of the ampliﬁcation products and
lack of unspeciﬁcities, was obtained using the SNPs C114A
(Rv0102) and C2565T (Rv2839) to investigate strains B and F,
respectively. We targeted the alleles present in strains other
than B and F and thus obtained two ampliﬁcation products for
these strains; in strains B and F, on the other hand, one of the
two amplicons disappeared alternatively for strain B and for
strain F (Figs 2(a) and (b)). We also prepared a second-line
conﬁrmatory oligonucleotide PCR, in this case to target SNPs
that were speciﬁc for strains B or F (Fig. 2(c)).TABLE 2. Clusters associated with active uncontrolled
transmission selected for surveillance
Cluster Subject no. Year of diagnosis Origin Place
B 1 2003 Spain Roquetas
2 2005 Spain Roquetas
3 2005 Spain Almería
4 2006 Spain Roquetas
5 2007 Spain Roquetas
6 2007 Senegal El Ejido
7 2008 Spain Roquetas
8 2008 Ghana Roquetas
9 2008 Nigeria Roquetas
10 2011 Spain Roquetas
11 2011 Spain Roquetas
12 2011 Spain Roquetas
13 2011 Morocco Roquetas
14 2011 Spain Roquetas
F 15 2007 Spain Roquetas
16 2007 Spain Roquetas
17 2007 Gambia Vícar
18 2008 Argentina Huercal-Overa
19 2008 Spain Roquetas
20 2008 Rumania Roquetas
21 2012 Spain Vícar
22 2012 Spain Roquetas
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectTRAP was initially validated with the 15 representatives of
clusters B and F that had not undergone WGS analysis
(Fig. 3(a)). It was then applied to a random selection of 57
isolates, different to B and F, from among the MTB isolates
previously genotyped by MIRU-VNTR, which were circulating
in the same region for the same period. The technique dis-
closed the expected patterns (Fig. 3(b)).
Evaluation of the TRAP assay directly on clinical
specimens
The optimum availability of results requires the technique to be
applied directly on stain-positive respiratory specimens. We
applied TRAP on 40 retrospectively selected stain-positive
decontaminated sputa that were representative of different
bacillary loads (1+ to 4+). Two ampliﬁcation products for
strains other than B or F were observed (Fig. 3(c)) in all cases,
even from those specimens with low bacteria load (1+).ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
FIG. 3. (a) TRAP patterns and conﬁrmatory PCR patterns obtained for the 10 and ﬁve additional representatives of clusters B and F, respectively. (b)
TRAP results for 15 representative isolates of the sample of 57 strains other than B and F. (c) TRAP patterns obtained from direct analysis of stain-
positive respiratory specimens. All cases corresponded to strains other than B or F. TRAP, targeted regional allele-speciﬁc oligonucleotide PCR; PCR,
polymerase chain reaction.
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The last step in the evaluation of TRAP was to transfer the
optimized protocol to the local laboratory in charge of diag-
nosing the cases among the population in which strains B and F
were being transmitted. This stage enabled us to evaluate the
transferability and robustness of TRAP.
In situ TRAP analysis updated in a single assay all 17 TB cases
(14 immigrant and three autochthonous) diagnosed in
Roquetas since the discontinuation of the universal MIRU-
VNTR analysis at the end of December 2012, together with
four additional cases (two immigrants and two autochtho-
nous) from the study period that were not typable. TRAP
results indicated that 19 cases were caused by a strain other
than B or F, whereas the two remaining cases were infections
caused by strains B and F (Fig. 4(a)). This assignation based on
TRAP was conﬁrmed by MIRU-VNTR. The infection by the B
strain corresponded to the reanalysis of a Spanish case from
2006 that could not be genotyped using MIRU-VNTR; the
infection by the F strain was a new autochthonous Spanish
case from 2013.
The ﬁnal step in the evaluation of the transferability of
TRAP to the local laboratory involved the analysis of the stain-
positive (1+ to 4+) respiratory specimens from 10 consecu-
tive cases. Again, the pattern for strains other than B and F
was obtained (Fig. 4(b)). A sputum sample from one strain F
case was also assayed, leading to the expected pattern
(Fig. 4(b)). The specimen for the case of strain B infection was
not available.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InDiscussionApplication of WGS in the epidemiologic analysis of MTB iso-
lates constitutes a revolutionary approach in the analysis of
transmission. WGS has proven to be more accurate than
MIRU-VNTR-based strategies for the deﬁnition of epidemio-
logically supported transmission clusters [3,4,16,17]. Recent
population-based retrospective studies by WGS show that a
genomic epidemiology strategy will soon be within our grasp
[5–7]. However, the switch towards WGS-based genomic
epidemiology in TB is infeasible in many settings because of cost
and the need for expertise. In addition, the technical complexity
involved in managing the data produced in the sequencing
analysis means that results are not available quickly enough to
be used in transmission control programs.
Our main objective was to deﬁne a novel strategy that en-
ables application of genome data to improve control of TB
transmission in clinical practice (Fig. 5). The design of our
strategy had to fulﬁll three conditions, as follows: low cost and
ease of use; availability of results sufﬁciently quickly to enable
appropriate intervention; and transferability to laboratories
diagnosing cases in populations where active transmission is
occurring.
Our ﬁrst requirement when attempting to develop a low-
cost strategy was to pay particular attention to surveillance of
previously described highly transmissible strains. Epidemiologic
resources are often too scarce to enable investigation andfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
FIG. 4. Patterns after transferring
TRAP to the local laboratory ob-
tained from (a) the 21 isolates ana-
lysed (17 from 2013–2014 and four
from those that could not be typed
by MIRU-VNTR). New cases infected
by strain F and B are indicated. The
conﬁrmatory PCR for these two
cases is also shown in the right panel.
(b) Ten sputa from independent
consecutive cases. TRAP result for
sputum from a case of infection by
strain F was included together with
the corresponding conﬁrmatory PCR
result (two last lanes). TRAP, tar-
geted regional allele-speciﬁc oligonu-
cleotide PCR; PCR, polymerase chain
reaction; MIRU-VNTR, mycobacte-
rial interspersed repetitive units–
variable number of tandem repeats.
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had to be tailored to track the most actively transmitted strains
in a speciﬁc setting. Similar efforts have been made elsewhere.
For example, strategies based on geographical information
systems were used to identify transmission hot spots where
intervention has to be prioritized [18]. Molecular tools have
also been tailored to speciﬁc MTB strains in other situations,
such as surveillance of the transmission of Beijing strains
[19,20]. These designs took advantage of the in-depth knowl-
edge accumulated for Beijing strains and the consequent easy
identiﬁcation of speciﬁc genetic features used as targets for
tailored PCRs. However, we do not have equivalent knowledge
of the genetic singularities of common strains that are actively
transmitted in a population but do not belong to high-risk
families. WGS now enables an in-depth analysis of any circu-
lating strain, thus making it possible to tailor tools optimized to
track them [21,22].
SNPs are the best strain-speciﬁc marker for MTB. They are
stable, as they do not reverse. In addition, homoplasy is rare in
MTB; therefore, it is highly unlikely that one SNP was shared by
two different strains [13,23]. After thoroughly comparing WGS
data from strains B and F and collecting a large number of se-
quences representative of different lineages and geographic
settings, we identiﬁed speciﬁc SNPs that enabled us to designClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectthe allele-speciﬁc PCRs included in our TRAP assay. In a single-
tube reaction, we were able to simultaneously survey several
actively transmitted strains and thus analyse transmission
globally.
The TRAP assay was evaluated in a pilot study among the
population of Almería, an area affected by active transmission of
TB, as indicated by the fact that 56% of the total cases of TB in
the study population were included in clusters. In addition, the
molecular epidemiology program based on MIRU-VNTR had
been suspended in this area as a result of funding restrictions.
Consequently, we had an excellent opportunity to evaluate new
low-cost strategies for rapid surveillance of problematic
transmission events.
The TRAP assay performed well for detecting cases of
infection by actively transmitted strains and for identifying in-
fections caused by other, different strains. Our second chal-
lenge was to ensure fast availability of results. Standard PCR-
based ﬁngerprinting markedly accelerated the speed at which
genotypes could be obtained compared to previous restriction
fragment length polymorphism–based schemes. MIRU-VNTR
analysis proved to be efﬁcient even for analysis of sputa
directly before culture, thus creating the optimal setting for
ﬁngerprinting of MTB isolates at diagnosis [8]. In addition,
resistance mutations can now be detected directly from clinicalious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
FIG. 5. Chart illustrating work ﬂow between the clinical setting, the genome and analysis center, and the TB research laboratory. (1) Strain X is
identiﬁed as belonging to an uncontrolled transmission cluster. Strains are analysed from raw sequencing data (2) to detect polymorphisms at the
genome sequencing center. (3) SNPs are detected after comparison of the strain X sequence with those of the reference strains. SNP1 is shared by the
strains belonging to the cluster and is not present in the global strain collection. (4) The TB research laboratory will use the transmission cluster–
speciﬁc SNP to design speciﬁc assays. We chose an alelle-speciﬁc-oligonucleotide PCR assay, TRAP, to distinguish between strains belonging to the
cluster. Once the assay is validated, it is easily transferred to a local clinical setting (5) for screening of ongoing surveillance (both from culture and from
direct samples) of the spread of the targeted highly transmissible strains and as support to the local TB control program. TB, tuberculosis; TRAP,
targeted regional allele-speciﬁc oligonucleotide PCR; PCR, polymerase chain reaction.
CMI Pérez-Lago et al. WGS-based in situ survey of TB transmission 249.e7specimens [24,25]. TRAP also enables genotyping analysis to be
performed directly on stain-positive clinical specimens, offering
a result even with low bacillary load (1+) specimens, thus
completing the information provided to clinicians or epidemi-
ologists at diagnosis.
Our ﬁnal challenge was to prove that the TRAP assay could
be easily transferred to the local laboratory. TRAP proved to be
transferable and robust, offering good performance regardless
of interlaboratory differences. After transfer, the technique was
successfully used to perform analyses directly from respiratory
specimens, thus illustrating the potential for real-time analysis
of transmission at diagnosis. Two new cases of infection by the
B and F strains were detected by the local laboratory—that is,
in the area where the strains are being transmitted. One isolate
corresponded to a new incident case and the other to an isolate
from a previous case (retrospectively detected) that could not
be typed using MIRU-VNTR. This observation illustrates that
TRAP can be applied in two ways: to prospectively survey a
well-known transmission event because standard molecularClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inepidemiology is already running; and to retrospectively analyse
the history of an identiﬁed transmission event in order to
investigate its causes and assess its dimension. As for pro-
spective application, TRAP can be applied systematically either
to all new incident cases in the region surveyed, or—taking
cost-effectiveness into account—to a speciﬁc proﬁle of cases
within that region. In the case of strains B and F, most of the
clustered cases and the new cases identiﬁed by TRAP were
autochthonous. If we had applied TRAP only to new incident
autochthonous cases, we would have identiﬁed new cases of
infection by B strains and new cases of infection by F strains,
with only four tests performed instead of the 21 needed when
application was based on geographical criteria.
Our intention is not to substitute universal molecular
epidemiology strategies with TRAP-based schemes but to
develop transferable tools to allow local laboratories to deal
with their own transmission challenges once the reference
laboratory has identiﬁed the most problematic strains based on
systematic ﬁngerprinting. TRAP assay is specially suitable forfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 249.e1–249.e9
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number of secondary cases, for the online survey of outbreaks
and to track multidrug-resistant TB transmission when it is
driven by a reduced number of strains. The adaptation of our
scheme to other settings means a new search of speciﬁc SNPs
for the strains to be surveyed and subsequent optimization of
allele-speciﬁc PCRs. New TRAP assays are being designed in
four different nodes representative for these situations for a
prospective multinational evaluation of our proposal beyond
the preliminary pilot analysis performed with two actively
transmitted strains in Almería.
In summary, TRAP reconciles highly reﬁned WGS data with
simple, PCR-based, low-cost schemes. Our proposal has the
following additional advantages: fast tracking of transmission, even
directly on clinical specimens; prioritization of resources towards
the most alarming transmission events; and decentralized sur-
veillance. TRAP could herald the transformation from a situation
in which a well-equipped central reference laboratory leads the
ﬁngerprinting tasks for the survey of TB transmission in different
populations to an alternativemultinodal decentralized structure of
laboratories dealing with their speciﬁc TB transmission issues in
situ. In this new scenario, the role of the reference center would
change in that it would be restricted to in-depth analysis of
problematic strains using WGS. In addition, it would provide
TRAP assays to local laboratories, thus giving them the possibility
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